Indivior Pharmaceuticals (INDV) Long-Term Debt Repayments (2022 - 2025)
Historic Long-Term Debt Repayments for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $4.0 million.
- Indivior Pharmaceuticals' Long-Term Debt Repayments rose 30000.0% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $250.0 million, marking a year-over-year increase of 86153.85%. This contributed to the annual value of $240.0 million for FY2024, which is 190000.0% up from last year.
- According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Long-Term Debt Repayments is $4.0 million, which was up 30000.0% from $4.0 million recorded in Q2 2025.
- Over the past 5 years, Indivior Pharmaceuticals' Long-Term Debt Repayments peaked at $238.0 million during Q4 2024, and registered a low of -$11.0 million during Q1 2023.
- Its 4-year average for Long-Term Debt Repayments is $24.4 million, with a median of $4.0 million in 2025.
- In the last 5 years, Indivior Pharmaceuticals' Long-Term Debt Repayments changed by 0.0% in 2023 and then skyrocketed by 89166.67% in 2024.
- Indivior Pharmaceuticals' Long-Term Debt Repayments (Quarter) stood at $5.0 million in 2022, then soared by 380.0% to $24.0 million in 2023, then soared by 891.67% to $238.0 million in 2024, then tumbled by 98.32% to $4.0 million in 2025.
- Its last three reported values are $4.0 million in Q3 2025, $4.0 million for Q2 2025, and $4.0 million during Q1 2025.